These medications carry a boxed warning about thyroid C-cell tumors observed in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Consult Your Doctor : If side effects become severe or persistent, consult your healthcare provider for guidance
[DOI] [PubMed] [Google Scholar] 135.Gao L., Lee B.W., Chawla M., Kim J., Huo L., Du L., Huang Y., Ji L
Employees should check their Summary Plan Description (SPD) for the phrase "anti-obesity medications excluded" before assuming coverage
Store according to laboratory protocol for topical research compounds
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes